Apyx Historical Income Statement

APYX Stock

USD 1.45 0.01 0.69%

Historical analysis of Apyx Medical income statement accounts such as Interest Expense of 2.6 M, Selling General Administrative of 51.3 M or Total Revenue of 26.2 M can show how well Apyx Medical performed in making a profits. Evaluating Apyx Medical income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Apyx Medical's future profits or losses.

Cash Flow Balance Sheet Income Statement

Dot-com Bubble

Housing Crash

Credit Downgrade

Yuan Drop

Covid

Financial Statement Analysis is much more than just reviewing and examining Apyx Medical latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Apyx Medical is a good buy for the upcoming year.

Net Income Gross Profit

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.

About Apyx Income Statement Analysis

Apyx Medical Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Apyx Medical shareholders. The income statement also shows Apyx investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).

Apyx Medical Income Statement Chart

At this time, Apyx Medical's Extraordinary Items is fairly stable compared to the past year. Reconciled Depreciation is likely to rise to about 870.7 K in 2024, whereas Total Revenue is likely to drop slightly above 26.2 M in 2024.

Selling General Administrative Total Revenue Gross Profit Other Operating Expenses

Total Revenue

Total revenue comprises all receipts Apyx Medical generated from the sale of its products or services. The total amount of income generated by the sale of goods or services related to the company's primary operations.

Gross Profit

Gross profit is a required income statement account that reflects total revenue of Apyx Medical minus its cost of goods sold. It is profit before Apyx Medical operating expenses, interest payments and taxes. Gross profit is also known as gross margin. The profit a company makes after deducting the costs associated with making and selling its products, or the costs associated with providing its services.

Other Operating Expenses

Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Apyx Medical. It is also known as Apyx Medical overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.

Most accounts from Apyx Medical's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Apyx Medical current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Apyx Medical. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in manufacturing.

For more information on how to buy Apyx Stock please use our How to Invest in Apyx Medical guide.At this time, Apyx Medical's Extraordinary Items is fairly stable compared to the past year. Reconciled Depreciation is likely to rise to about 870.7 K in 2024, whereas Total Revenue is likely to drop slightly above 26.2 M in 2024.

	2021	2022	2023	2024 (projected)
Interest Expense	10K	15K	2.5M	2.6M
Depreciation And Amortization	903K	890K	692K	736.2K

Interest Expense Depreciation And Amortization

Apyx Medical income statement Correlations

	Depreciation And Amortization	Interest Expense	Selling General Administrative	Total Revenue	Gross Profit	Other Operating Expenses	Operating Income	Ebit	Research Development	Ebitda	Cost Of Revenue	Total Operating Expenses	Income Before Tax	Total Other Income Expense Net	Net Income	Income Tax Expense	Net Income From Continuing Ops	Non Operating Income Net Other	Selling And Marketing Expenses	Tax Provision	Interest Income	Discontinued Operations	Net Interest Income	Extraordinary Items	Reconciled Depreciation	Minority Interest
Depreciation And Amortization		-0.15	0.34	0.47	0.51	0.42	-0.34	-0.33	0.37	-0.3	0.11	0.34	-0.34	0.04	-0.29	0.04	-0.42	-0.1	-0.21	0.0	-0.06	0.21	0.33	0.21	0.31	-0.24
Interest Expense	-0.15		0.53	0.22	-0.18	0.54	-0.27	-0.34	0.51	-0.34	0.87	0.49	-0.41	-0.5	-0.12	-0.26	-0.24	0.18	0.86	-0.26	-0.2	0.49	-0.61	0.49	0.17	0.22
Selling General Administrative	0.34	0.53		0.66	0.66	0.97	-0.88	-0.9	0.99	-0.9	0.55	1.0	-0.89	-0.09	-0.4	-0.29	-0.8	0.35	0.34	-0.29	-0.67	0.89	-0.05	0.89	0.79	-0.49
Total Revenue	0.47	0.22	0.66		0.76	0.77	-0.43	-0.44	0.67	-0.43	0.52	0.66	-0.45	-0.09	-0.49	0.1	-0.47	0.11	0.29	0.12	-0.6	0.35	-0.21	0.35	0.43	-0.52
Gross Profit	0.51	-0.18	0.66	0.76		0.69	-0.58	-0.56	0.67	-0.55	0.06	0.69	-0.48	0.28	-0.34	0.02	-0.54	0.25	-0.2	0.08	-0.7	0.47	0.23	0.47	0.69	-0.79
Other Operating Expenses	0.42	0.54	0.97	0.77	0.69		-0.79	-0.81	0.97	-0.8	0.67	0.97	-0.82	-0.16	-0.48	-0.18	-0.76	0.27	0.44	-0.19	-0.68	0.77	-0.16	0.77	0.74	-0.48
Operating Income	-0.34	-0.27	-0.88	-0.43	-0.58	-0.79		1.0	-0.88	1.0	-0.19	-0.89	0.96	-0.04	0.24	0.42	0.87	-0.31	-0.01	0.45	0.55	-0.91	-0.31	-0.91	-0.73	0.46
Ebit	-0.33	-0.34	-0.9	-0.44	-0.56	-0.81	1.0		-0.9	1.0	-0.25	-0.91	0.97	-0.01	0.24	0.42	0.87	-0.32	-0.07	0.45	0.54	-0.93	-0.26	-0.93	-0.72	0.44
Research Development	0.37	0.51	0.99	0.67	0.67	0.97	-0.88	-0.9		-0.89	0.55	0.99	-0.87	-0.04	-0.36	-0.36	-0.75	0.39	0.33	-0.35	-0.71	0.88	-0.02	0.88	0.77	-0.43
Ebitda	-0.3	-0.34	-0.9	-0.43	-0.55	-0.8	1.0	1.0	-0.89		-0.25	-0.91	0.97	-0.01	0.24	0.42	0.87	-0.32	-0.07	0.45	0.55	-0.93	-0.26	-0.93	-0.72	0.44
Cost Of Revenue	0.11	0.87	0.55	0.52	0.06	0.67	-0.19	-0.25	0.55	-0.25		0.52	-0.35	-0.54	-0.42	0.0	-0.28	0.03	0.92	-0.03	-0.28	0.3	-0.71	0.3	0.22	0.08
Total Operating Expenses	0.34	0.49	1.0	0.66	0.69	0.97	-0.89	-0.91	0.99	-0.91	0.52		-0.89	-0.06	-0.39	-0.29	-0.8	0.36	0.3	-0.29	-0.69	0.89	-0.02	0.89	0.8	-0.51
Income Before Tax	-0.34	-0.41	-0.89	-0.45	-0.48	-0.82	0.96	0.97	-0.87	0.97	-0.35	-0.89		0.24	0.3	0.32	0.94	-0.09	-0.16	0.43	0.5	-0.89	-0.16	-0.89	-0.69	0.4
Total Other Income Expense Net	0.04	-0.5	-0.09	-0.09	0.28	-0.16	-0.04	-0.01	-0.04	-0.01	-0.54	-0.06	0.24		0.14	-0.25	0.31	0.74	-0.52	0.01	-0.05	-0.03	0.47	-0.03	0.1	-0.21
Net Income	-0.29	-0.12	-0.4	-0.49	-0.34	-0.48	0.24	0.24	-0.36	0.24	-0.42	-0.39	0.3	0.14		-0.28	0.4	0.1	-0.3	-0.25	0.06	-0.07	0.21	-0.07	-0.49	0.28
Income Tax Expense	0.04	-0.26	-0.29	0.1	0.02	-0.18	0.42	0.42	-0.36	0.42	0.0	-0.29	0.32	-0.25	-0.28		0.01	-0.52	0.01	0.89	0.36	-0.51	-0.04	-0.51	-0.32	-0.2
Net Income From Continuing Ops	-0.42	-0.24	-0.8	-0.47	-0.54	-0.76	0.87	0.87	-0.75	0.87	-0.28	-0.8	0.94	0.31	0.4	0.01		0.12	-0.06	0.15	0.38	-0.74	-0.23	-0.74	-0.63	0.52
Non Operating Income Net Other	-0.1	0.18	0.35	0.11	0.25	0.27	-0.31	-0.32	0.39	-0.32	0.03	0.36	-0.09	0.74	0.1	-0.52	0.12		0.08	-0.22	-0.32	0.38	0.11	0.38	0.25	-0.09
Selling And Marketing Expenses	-0.21	0.86	0.34	0.29	-0.2	0.44	-0.01	-0.07	0.33	-0.07	0.92	0.3	-0.16	-0.52	-0.3	0.01	-0.06	0.08		0.0	-0.18	0.12	-0.74	0.12	-0.02	0.31
Tax Provision	0.0	-0.26	-0.29	0.12	0.08	-0.19	0.45	0.45	-0.35	0.45	-0.03	-0.29	0.43	0.01	-0.25	0.89	0.15	-0.22	0.0		0.34	-0.52	-0.03	-0.52	-0.31	-0.26
Interest Income	-0.06	-0.2	-0.67	-0.6	-0.7	-0.68	0.55	0.54	-0.71	0.55	-0.28	-0.69	0.5	-0.05	0.06	0.36	0.38	-0.32	-0.18	0.34		-0.55	0.1	-0.55	-0.59	0.44
Discontinued Operations	0.21	0.49	0.89	0.35	0.47	0.77	-0.91	-0.93	0.88	-0.93	0.3	0.89	-0.89	-0.03	-0.07	-0.51	-0.74	0.38	0.12	-0.52	-0.55		0.15	1.0	0.71	-0.36
Net Interest Income	0.33	-0.61	-0.05	-0.21	0.23	-0.16	-0.31	-0.26	-0.02	-0.26	-0.71	-0.02	-0.16	0.47	0.21	-0.04	-0.23	0.11	-0.74	-0.03	0.1	0.15		0.15	-0.01	-0.1
Extraordinary Items	0.21	0.49	0.89	0.35	0.47	0.77	-0.91	-0.93	0.88	-0.93	0.3	0.89	-0.89	-0.03	-0.07	-0.51	-0.74	0.38	0.12	-0.52	-0.55	1.0	0.15		0.71	-0.36
Reconciled Depreciation	0.31	0.17	0.79	0.43	0.69	0.74	-0.73	-0.72	0.77	-0.72	0.22	0.8	-0.69	0.1	-0.49	-0.32	-0.63	0.25	-0.02	-0.31	-0.59	0.71	-0.01	0.71		-0.65
Minority Interest	-0.24	0.22	-0.49	-0.52	-0.79	-0.48	0.46	0.44	-0.43	0.44	0.08	-0.51	0.4	-0.21	0.28	-0.2	0.52	-0.09	0.31	-0.26	0.44	-0.36	-0.1	-0.36	-0.65

Click cells to compare fundamentals

Apyx Medical Account Relationship Matchups

Apyx Medical income statement Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Depreciation And Amortization	1.0M	887K	903K	890K	692K	736.2K
Interest Expense	8K	46K	10K	15K	2.5M	2.6M
Selling General Administrative	36.2M	33.7M	43.7M	48.1M	48.9M	51.3M
Total Revenue	28.2M	27.7M	48.5M	44.5M	52.3M	26.2M
Gross Profit	19.1M	17.5M	33.6M	29.1M	14.1M	12.4M
Other Operating Expenses	49.1M	47.8M	63.0M	68.1M	69.6M	73.1M
Operating Income	(20.9M)	(20.1M)	(14.4M)	(23.6M)	(17.3M)	(16.4M)
Ebit	(20.9M)	(19.4M)	(14.8M)	(22.9M)	(18.8M)	(17.9M)
Research Development	3.8M	3.9M	4.3M	4.5M	4.8M	5.1M
Ebitda	(19.9M)	(18.5M)	(13.9M)	(22.0M)	(18.1M)	(17.2M)
Cost Of Revenue	9.0M	10.2M	14.9M	15.4M	38.2M	40.1M
Total Operating Expenses	40.0M	37.6M	48.0M	52.7M	51.0M	53.6M
Income Before Tax	(19.9M)	(19.4M)	(14.8M)	(22.9M)	(21.3M)	(20.2M)
Total Other Income Expense Net	1.0M	674K	(372K)	651K	(4.0M)	(3.8M)
Net Income	(19.7M)	(11.9M)	(15.2M)	(23.3M)	(18.7M)	(17.8M)
Income Tax Expense	(260K)	(7.5M)	380K	367K	(2.4M)	(2.3M)
Net Income Applicable To Common Shares	(19.7M)	(11.9M)	(15.2M)	(23.2M)	(20.9M)	(19.8M)
Net Income From Continuing Ops	(19.7M)	(11.9M)	(15.2M)	(23.3M)	(15.3M)	(16.1M)
Non Operating Income Net Other	1.0M	674K	(372K)	651K	748.7K	786.1K
Tax Provision	(130K)	(7.5M)	380K	367K	(2.4M)	(2.2M)
Interest Income	1.4M	241K	11K	157K	542K	421.4K
Net Interest Income	1.4M	195K	1K	142K	(823K)	(781.9K)
Reconciled Depreciation	754K	887K	903K	890K	742K	870.7K

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

RSI	Rush Street Interactive
OKTA	Okta Inc
BAC	Bank of America

Additional Tools for Apyx Stock Analysis

When running Apyx Medical's price analysis, check to measure Apyx Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Apyx Medical is operating at the current time. Most of Apyx Medical's value examination focuses on studying past and present price action to predict the probability of Apyx Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Apyx Medical's price. Additionally, you may evaluate how the addition of Apyx Medical to your portfolios can decrease your overall portfolio volatility.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Apyx Historical Income Statement

About Apyx Income Statement Analysis

Apyx Medical Income Statement Chart

Total Revenue

Gross Profit

Other Operating Expenses

Apyx Medical income statement Correlations

Apyx Medical Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Apyx Medical income statement Accounts

Also Currently Popular

Additional Tools for Apyx Stock Analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Operating Expenses	+ 1.0	Selling General Administrative
Ebit	+ 1.0	Operating Income
Ebitda	+ 1.0	Operating Income
Ebitda	+ 1.0	Ebit
Extraordinary Items	+ 1.0	Discontinued Operations
Research Development	+ 0.99	Selling General Administrative

Extraordinary Items	- 0.93	Ebitda
Discontinued Operations	- 0.93	Ebitda
Extraordinary Items	- 0.93	Ebit
Discontinued Operations	- 0.93	Ebit
Total Operating Expenses	- 0.91	Ebitda
Total Operating Expenses	- 0.91	Ebit